Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
arena pharmaceuticals | 1.88 | 0.3 | 8341 | 72 | 21 |
arena | 1.96 | 0.8 | 1212 | 23 | 5 |
pharmaceuticals | 1.21 | 1 | 1918 | 4 | 15 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
arena pharmaceuticals | 1.34 | 0.3 | 1890 | 60 |
arena pharmaceuticals stock | 0.41 | 0.7 | 1672 | 70 |
arena pharmaceuticals pfizer | 0.17 | 0.4 | 2017 | 80 |
arena pharmaceuticals news | 1.88 | 0.3 | 3672 | 100 |
arena pharmaceuticals myocarditis | 0.65 | 0.5 | 6856 | 42 |
arena pharmaceuticals stock price | 0.8 | 0.1 | 1670 | 97 |
arena pharmaceuticals gmbh | 0.05 | 0.3 | 1801 | 4 |
arena pharmaceuticals yahoo finance | 1.5 | 0.3 | 9031 | 84 |
arena pharmaceuticals careers | 1.19 | 0.5 | 8596 | 16 |
arena pharmaceuticals pipeline | 1.81 | 0.3 | 7187 | 47 |
arena pharmaceuticals yahoo | 0.87 | 1 | 1989 | 74 |
arena pharmaceuticals aktie | 1.48 | 0.1 | 9249 | 50 |
pfizer buys arena pharmaceuticals | 1.46 | 0.3 | 8837 | 24 |
pfizer bought arena pharmaceuticals | 1.78 | 0.1 | 7323 | 8 |
arena pharmaceuticals inc | 1.07 | 0.7 | 1633 | 54 |
what does arena pharmaceuticals make | 1.84 | 0.4 | 9452 | 6 |
pfizer acquires arena pharmaceuticals | 0.22 | 0.8 | 4172 | 65 |
who owns arena pharmaceuticals | 0.15 | 0.6 | 335 | 84 |
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-arena-pharmaceuticals
WEBMar 11, 2022 · Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases …
DA: 21 PA: 4 MOZ Rank: 33 Up or Down: Up
https://en.wikipedia.org/wiki/Arena_Pharmaceuticals
WEBArena Pharmaceuticals Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. Arena focused on discovering drugs that act on G protein-coupled receptors (GPCRs). The company developed technology it called Constitutively Activated Receptor Technology (CART) that identified drug leads targeting ...
DA: 89 PA: 57 MOZ Rank: 41 Up or Down: Up
https://www.cnbc.com/2021/12/13/pfizer-to-acquire-arena-pharmaceuticals-in-6point7-billion-deal-.html
WEBDec 13, 2021 · Key Points. Pfizer said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach...
DA: 51 PA: 97 MOZ Rank: 18 Up or Down: Up
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-acquire-arena-pharmaceuticals
WEBDec 13, 2021 · Pfizer to Acquire Arena Pharmaceuticals. Proposed acquisition offerspotentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases. Expands innovative pipeline potentially enhancing growth through 2025 and beyond. Transaction valued at …
DA: 40 PA: 49 MOZ Rank: 17 Up or Down: Up
https://www.businesswire.com/news/home/20211213005204/en/Pfizer-to-Acquire-Arena-Pharmaceuticals
WEBDec 13, 2021 · NEW YORK & PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement...
DA: 58 PA: 68 MOZ Rank: 100 Up or Down: Up
https://www.pharmaceutical-technology.com/news/pfizer-arena-pharmaceuticals-acquisition/
WEBMar 14, 2022 · Pfizer has concluded the takeover of the complete outstanding shares, options and restricted stock units of clinical-stage firm Arena Pharmaceuticals for an equity price of nearly $6.7bn or $100 for each share in cash. In December last year, Pfizer entered a definitive agreement to acquire Arena.
DA: 58 PA: 6 MOZ Rank: 65 Up or Down: Down
https://www.biopharmadive.com/news/pfizer-acquires-arena-pharmaceuticals-inflammation-drugs/611383/
WEBDec 13, 2021 · Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio of inflammation drugs. Pfizer will buy Arena for $100 per share in cash, more than double the biotech’s closing price on Friday.
DA: 66 PA: 4 MOZ Rank: 99 Up or Down: Up
https://www.wsj.com/articles/pfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813
WEBDec 13, 2021 · Pfizer Inc. agreed to acquire Arena Pharmaceuticals Inc. for $6.7 billion, bolstering the pharmaceutical giant’s pipeline of medicines for inflammatory bowel diseases. Pfizer will pay Arena ...
DA: 38 PA: 20 MOZ Rank: 49 Up or Down: Up
https://apnews.com/article/business-arena-pharmaceuticals-inc-7a6a71584083bb886af7042f221180a5
WEBDec 13, 2021 · The pharmaceutical giant said Monday it will pay $100 in cash for each share of Arena Pharmaceuticals in a deal already approved by the boards of both companies. Shares of Arena nearly doubled after the deal was announced Monday. Pfizer believes that Arena will bolster its expertise in inflammation and immunology.
DA: 99 PA: 41 MOZ Rank: 52 Up or Down: Up
https://www.forbes.com/companies/arena-pharmaceuticals/
WEBArena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers ...
DA: 50 PA: 92 MOZ Rank: 39 Up or Down: Up
https://www.businesswire.com/news/home/20210302006098/en/Arena-Pharmaceuticals-Reports-Topline-Results-from-Phase-2b-CAPTIVATE-Clinical-Trial
WEBMarch 02, 2021 04:05 PM Eastern Standard Time. PARK CITY, Utah-- ( BUSINESS WIRE )-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced topline results from the randomized, double-blind ...
DA: 77 PA: 18 MOZ Rank: 76 Up or Down: Up
https://www.fiercebiotech.com/biotech/pfizer-tosses-newly-acquired-meds-out-arena-part-midstage-cleaning
WEBMay 2, 2023 · Pfizer has taken the broom to three midstage medicines from the acquisition of Arena Pharmaceuticals, deciding that etrasimod alone was worthy of the biotech’s $6.7 billion price tag. | Pfizer...
DA: 17 PA: 90 MOZ Rank: 6 Up or Down: Up
https://cardiovascularbusiness.com/topics/healthcare-management/healthcare-economics/pfizer-finalizes-67-billion-acquisition-arena
WEBMichael Walter | March 14, 2022 | Cardiovascular Business | Economics. Pfizer has completed its $6.7 billion acquisition of Arena Pharmaceuticals, finalizing a deal that involves multiple cardiovascular properties. The transaction was first announced back in December 2021.
DA: 29 PA: 70 MOZ Rank: 89 Up or Down: Down
https://marketrealist.com/p/arena-pharmaceuticals-pipeline/
WEBDec 13, 2021 · Pfizer makes an acquisition. Buying immuno-inflammatory drug maker Arena Pharmaceuticals for $6.7 billion in cash. Values Arena at $100 a share. $ARNA up 93% #premarket. $PFE up 1%.
DA: 66 PA: 85 MOZ Rank: 50 Up or Down: Up
https://www.linkedin.com/company/arena-pharmaceuticals
WEBArena is now part of Pfizer. Website. http://www.pfizer.com. Industry. Pharmaceutical Manufacturing. Company size. 201-500 employees. Headquarters. San Diego, CA.
DA: 10 PA: 1 MOZ Rank: 95 Up or Down: Up
https://www.businesswire.com/news/home/20220310005794/en/Pfizer-Completes-Acquisition-of-Arena-Pharmaceuticals
WEBMar 11, 2022 · Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral ...
DA: 67 PA: 6 MOZ Rank: 77 Up or Down: Up
https://www.marketscreener.com/quote/stock/ARENA-PHARMACEUTICALS-35897659/
WEBArena Pharmaceuticals, Inc. is a biopharmaceutical company focused on delivering transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. The Company's clinical programs include Etrasimod, which is an oral, selective sphingosine 1-phosphate (S1P), receptor modulator, designed to provide systemic and ...
DA: 54 PA: 53 MOZ Rank: 8 Up or Down: Up
https://www.fiercebiotech.com/biotech/connect-biopharma-uncouples-pfizer-scrapping-long-standing-eczema-pact
WEB3 days ago · Chinese-American biotech Connect licensed the oral, peripherally acting H3R antagonist, dubbed CBP-174, in 2012 from Arena Pharmaceuticals, a company that Pfizer bought for $6.7 billion a decade ...
DA: 21 PA: 58 MOZ Rank: 69 Up or Down: Up
https://www.globenewswire.com/news-release/2024/04/19/2866028/0/en/Global-Vision-Care-Market-Projected-to-Surpass-US-102-Billion-by-2030-as-Demand-for-Advanced-Eye-Care-Solutions-Grows.html
WEB1 day ago · Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Vision Care Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report ...
DA: 80 PA: 36 MOZ Rank: 29 Up or Down: Up
https://www.arenaco.com/
WEBArena Investors is a global institutional asset manager that provides creative solutions for those seeking capital in special situations. With more than 100 people across seven global offices and operating in 20 countries, we often provide capital where others won’t.
DA: 73 PA: 37 MOZ Rank: 2 Up or Down: Up
https://www.noven.com/about/history/
WEBOur Story. Noven – 1987 to Today. Noven's history began in 1987 in Miami, Florida, with the mission to develop differentiated prescription transdermal drug delivery systems (patches) to benefit patients across a range of therapeutic conditions.
DA: 87 PA: 35 MOZ Rank: 69 Up or Down: Up
https://www.linkedin.com/company/prosolus-pharmaceuticals
WEBProSolus, Inc. | 736 followers on LinkedIn. Transforming transdermal delivery | ProSolus Pharmaceuticals delivers sophisticated transdermal solutions customized to meet your needs and exceed your ...
DA: 27 PA: 59 MOZ Rank: 66 Up or Down: Up
https://www.pfizer.com/
WEB175 Years of Pfizer Breakthroughs. We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer ...
DA: 79 PA: 77 MOZ Rank: 34 Up or Down: Up
https://www.thestreet.com/investing/stocks/analyst-updates-johnson-johnson-stock-price-target-after-earnings
WEB1 day ago · On April 16, Johnson & Johnson reported first-quarter earnings of $2.71 per share, beating FactSet's consensus of $2.66. Revenue totaled $21.38 billion, compared with FactSet's call for $21.40 ...
DA: 99 PA: 8 MOZ Rank: 98 Up or Down: Up
https://www.marketwatch.com/investing/stock/arna?countryCode=id
WEBරු.11.67B. Asian Granito India Ltd. -0.82%. ₹6.39B. ARNA | Complete Arwana Citramulia stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
DA: 70 PA: 12 MOZ Rank: 56 Up or Down: Up
https://www.reuters.com/sports/nhl-roundup-capitals-clip-flyers-land-playoff-berth-2024-04-17/
WEB3 days ago · T.J. Oshie scored the winning goal into an empty net with three minutes remaining as the visiting Washington Capitals clinched a playoff spot with a 2-1 win against the Philadelphia Flyers on Tuesday.
DA: 60 PA: 84 MOZ Rank: 44 Up or Down: Up
https://www.pfizer.com/print/pdf/node/553446
WEBFriday, March 11, 2022 - 08:34am. NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.
DA: 60 PA: 53 MOZ Rank: 20 Up or Down: Up
https://www.reuters.com/sports/clark-effect-mystics-host-fever-capital-one-arena-2024-04-18/
WEB1 day ago · The Mystics are moving their June 7 date from the 4,200-seat Entertainment & Sports Arena to the 20,000-seat Capital One Arena, home of the NBA's Wizards and NHL's Capitals.
DA: 59 PA: 78 MOZ Rank: 56 Up or Down: Up